Date of response: 3 July 2026

Outcome: Information not disclosed

Category: Medicines Optimisation

Request

HAE high-cost-drug (Blueteq) approvals

ICB Response

NN ICB 26 1649 Response Letter Final

pdf (181K)

Close
Search